Mahon Paul A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Nov 4, 2021
- Accession no.
- 0001127602-21-028392
- Filed
- Nov 4, 2021
- Trade date
- Nov 4, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.21M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mahon Paul ACIK 0001231589 | Officer (EVP & General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2021 | Common Stock | MOption exerciseAcquired | +6,000 | $111.00 | +$666,000 | 42,369 | Direct | |
| Nov 4, 2021 | Common Stock | SSaleDisposed | −3,800 | $200.65F2 | −$762,470 | 38,569 | Direct | |
| Nov 4, 2021 | Common Stock | SSaleDisposed | −1,400 | $201.84F3 | −$282,576 | 37,169 | Direct | |
| Nov 4, 2021 | Common Stock | SSaleDisposed | −800 | $202.64 | −$162,112 | 36,369 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 4, 2021 | Common Stock | MOption exerciseDisposed | −6,000 | $0.00 | $0 | 51,458 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $200.1050 to 200.9850. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $201.51 to $202.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.